Pricing, patent loss and the market for pharmaceuticals:
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
National Bureau for Economic Research
1991
|
| Schriftenreihe: | Working paper series / National Bureau of Economic Research
3803 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 34 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV022653399 | ||
| 003 | DE-604 | ||
| 005 | 20160608 | ||
| 007 | t | ||
| 008 | 070828s1991 |||| 00||| eng d | ||
| 035 | |a (OCoLC)24457486 | ||
| 035 | |a (DE-599)BSZ025767992 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-83 |a DE-20 | ||
| 050 | 0 | |a HB1 | |
| 100 | 1 | |a Frank, Richard G. |e Verfasser |0 (DE-588)124918840 |4 aut | |
| 245 | 1 | 0 | |a Pricing, patent loss and the market for pharmaceuticals |c Richard G. Frank ; David S. Salkever |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau for Economic Research |c 1991 | |
| 300 | |a 34 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Working paper series / National Bureau of Economic Research |v 3803 | |
| 650 | 4 | |a Drugs |v Patents | |
| 650 | 4 | |a Drugs |x Generic substitution |x Economic aspects | |
| 650 | 4 | |a Generic drugs | |
| 650 | 4 | |a Pharmaceutical industry |z United States | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Salkever, David S. |e Verfasser |0 (DE-588)128737212 |4 aut | |
| 810 | 2 | |a National Bureau of Economic Research |t Working paper series |v 3803 |w (DE-604)BV002801238 |9 3803 | |
| 856 | 4 | 1 | |u http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2685 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015859371 | ||
Datensatz im Suchindex
| _version_ | 1804136831505137665 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Frank, Richard G. Salkever, David S. |
| author_GND | (DE-588)124918840 (DE-588)128737212 |
| author_facet | Frank, Richard G. Salkever, David S. |
| author_role | aut aut |
| author_sort | Frank, Richard G. |
| author_variant | r g f rg rgf d s s ds dss |
| building | Verbundindex |
| bvnumber | BV022653399 |
| callnumber-first | H - Social Science |
| callnumber-label | HB1 |
| callnumber-raw | HB1 |
| callnumber-search | HB1 |
| callnumber-sort | HB 11 |
| callnumber-subject | HB - Economic Theory and Demography |
| collection | ebook |
| ctrlnum | (OCoLC)24457486 (DE-599)BSZ025767992 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01361nam a2200373 cb4500</leader><controlfield tag="001">BV022653399</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20160608 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">070828s1991 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)24457486</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BSZ025767992</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-83</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Frank, Richard G.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)124918840</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pricing, patent loss and the market for pharmaceuticals</subfield><subfield code="c">Richard G. Frank ; David S. Salkever</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau for Economic Research</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">34 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Working paper series / National Bureau of Economic Research</subfield><subfield code="v">3803</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="v">Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Generic substitution</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Generic drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salkever, David S.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)128737212</subfield><subfield code="4">aut</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">National Bureau of Economic Research</subfield><subfield code="t">Working paper series</subfield><subfield code="v">3803</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">3803</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2685</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015859371</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV022653399 |
| illustrated | Not Illustrated |
| index_date | 2024-07-02T18:22:18Z |
| indexdate | 2024-07-09T21:02:39Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015859371 |
| oclc_num | 24457486 |
| open_access_boolean | 1 |
| owner | DE-19 DE-BY-UBM DE-83 DE-20 |
| owner_facet | DE-19 DE-BY-UBM DE-83 DE-20 |
| physical | 34 S. |
| psigel | ebook |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | National Bureau for Economic Research |
| record_format | marc |
| series2 | Working paper series / National Bureau of Economic Research |
| spelling | Frank, Richard G. Verfasser (DE-588)124918840 aut Pricing, patent loss and the market for pharmaceuticals Richard G. Frank ; David S. Salkever Cambridge, Mass. National Bureau for Economic Research 1991 34 S. txt rdacontent n rdamedia nc rdacarrier Working paper series / National Bureau of Economic Research 3803 Drugs Patents Drugs Generic substitution Economic aspects Generic drugs Pharmaceutical industry United States USA Salkever, David S. Verfasser (DE-588)128737212 aut National Bureau of Economic Research Working paper series 3803 (DE-604)BV002801238 3803 http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2685 Verlag kostenfrei Volltext |
| spellingShingle | Frank, Richard G. Salkever, David S. Pricing, patent loss and the market for pharmaceuticals Drugs Patents Drugs Generic substitution Economic aspects Generic drugs Pharmaceutical industry United States |
| title | Pricing, patent loss and the market for pharmaceuticals |
| title_auth | Pricing, patent loss and the market for pharmaceuticals |
| title_exact_search | Pricing, patent loss and the market for pharmaceuticals |
| title_exact_search_txtP | Pricing, patent loss and the market for pharmaceuticals |
| title_full | Pricing, patent loss and the market for pharmaceuticals Richard G. Frank ; David S. Salkever |
| title_fullStr | Pricing, patent loss and the market for pharmaceuticals Richard G. Frank ; David S. Salkever |
| title_full_unstemmed | Pricing, patent loss and the market for pharmaceuticals Richard G. Frank ; David S. Salkever |
| title_short | Pricing, patent loss and the market for pharmaceuticals |
| title_sort | pricing patent loss and the market for pharmaceuticals |
| topic | Drugs Patents Drugs Generic substitution Economic aspects Generic drugs Pharmaceutical industry United States |
| topic_facet | Drugs Patents Drugs Generic substitution Economic aspects Generic drugs Pharmaceutical industry United States USA |
| url | http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2685 |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT frankrichardg pricingpatentlossandthemarketforpharmaceuticals AT salkeverdavids pricingpatentlossandthemarketforpharmaceuticals |